- ►129.237.146.186 [PDF] H Kourlas, DS Schiller - Clinical therapeutics, 2006 - Elsevier Only 1 research group has evaluated the tolerability and efficacy of pegaptanib in patients with
neovascular ARMD. The VEGF Inhibition Study in Ocular Neovascularization involved 2 concurrent
randomized trials of intravitreous injections of pegaptanib 0.3 mg (n = 294), 1 mg (n = ... Cited by 36 - Related articles - All 4 versions
GC Brown, MM Brown, J Campanella, GR … - American journal of …, 2005 - Elsevier Five-year visual acuity data from the TAP (Treatment of Age-related Macular Degeneration With
Photodynamic Therapy) Investigation were modeled into a 12-year, value-based, reference
case, cost-utility model utilizing year 2004 Medicare costs and an outcome of $/QALY ( ... Cited by 35 - Related articles - All 5 versions
GW Bylsma, RH Guymer - Clin Exp Optom, 2005 - grande.nal.usda.gov Title: Treatment of age-related macular degeneration. Author: Bylsma,-GW; Guymer,-RH
Citation: Clin-Exp-Optom. 2005 Sep; 88(5): 322-34 Abstract: Age-related macular degeneration
(AMD) is the greatest cause of legal blindness in the western world. Established ... Cited by 21 - Related articles - Cached - All 5 versions
S Mennel, I Barbazetto, CH Meyer, S Peter, M … - Ophthalmologica, 2007 - content.karger.com Ocular photodynamic therapy (PDT) was introduced as a novel treatment for neovascular forms
of age-related macular degeneration and choroidal neovascularization (CNV) secondary to pathologic
myopia in the mid/end 1990s. The current treatment recommendations are based on the ... Cited by 18 - Related articles - BL Direct - All 7 versions
MB Gorin - Archives of Ophthalmology, 2007 - Am Med Assoc Molecular genetic studies of age-related maculopathy (ARM), including family-based linkage
studies and case-control association studies, have yielded valuable insights into the risks of
developing this condition and potential disease-causing mechanisms. Variants in the ... Cited by 20 - Related articles - BL Direct - All 5 versions
WE Smiddy - Ophthalmology, 2007 - Elsevier Several parameters to estimate Snellen lines of vision saved were defined and tabulated for
each condition. A regimen of office visits, ancillary testing, and treatments was outlined. Costs
for this were tabulated using Medicare-allowable costs, and costs of visual benefit (per ... Cited by 10 - Related articles - All 18 versions
N Bansback, S Davis, J Brazier - Eye, 2006 - nature.com A health economic model is used to synthesise the evidence on contrast sensitivity and treatment
rates from the TAP Investigation with health state utilities and costs. Impairment of visual function
is estimated using a Markov model to predict transitions between states of contrast ... Cited by 11 - Related articles - BL Direct - All 3 versions
- ►adisonline.com [PDF] JK Schmier, ML Jones, MT Halpern - Pharmacoeconomics, 2006 - ingentaconnect.com As age-related macular degeneration (AMD) becomes more prevalent as a Abstract result of
longer life expectancy and the number of elderly people worldwide, it will become increasingly
important to understand its potential health and econom- ic impact for appropriate ... Cited by 9 - Related articles - BL Direct - All 7 versions
- ►augenaerzte-baden-baden.de [PDF] AJ Augustin, I Offermann - Expert Opin. Emerging Drugs, 2006 - informahealthcare.com Age-related macular degeneration (AMD) is a leading cause of blindness that until recently had
no recognised drug treatment. In wet AMD, choroidal neovascularisation (CNV) causes a profound
loss of central vision. CNV is a complex process in which tissue ischaemia and/or ... Cited by 8 - Related articles - All 7 versions
- ►v2020la.org [PDF] EL Lamoureux, SL Chou, MF Larizza, JE … - Ophthalmic …, 2006 - informahealthcare.com Purpose: To determine the reliability of vision-related personal costs collected over 1, 3 and 6
months (extrapolated to 12 months) compared to one-year data. Methods: Participants of any
age, with a presenting visual acuity of < 20/40 in the better eye and an ability to converse ... Cited by 6 - Related articles - BL Direct - All 6 versions
